STAT Plus: Novo Nordisk’s Jorgensen: If it was easy to correct pricing, we would be doing it already
"If a patient on a high-deductible plan is asked to pay list price of $300, we get one-third of what the patient pays, which is crazy," Jorgensen says.
No hay comentarios:
Publicar un comentario